Neonates, especially those who are premature or have low birth weight, are at increased risk for invasive fungal infections. These infections can be life-threatening and require prompt, effective treatment. Echinocandins are often preferred in neonates due to their fungicidal activity against Candida species and their relatively favorable safety profile compared to other antifungal agents.
